Abstract

Objective: A palpable lymph node in the physical examination may pose a distressing situation for both the parents and the physician who is following the child. We aimed to prospectively document the value of clinical and laboratory findings in children with lymphadenomegaly.

Material and Methods: Two hundred twenty-three children aged 0.3 to 17.5 years with lymphadenomegaly diagnosed during general physical examinations and referred to Eskisehir State Hospital Pediatric Hematology/Oncology outpatient clinic for the first time between 1 September 2013 and 31 August 2014 were included in the study.

Results: Seventy-one patients (32%) were female. Benign causes were detected in 217 (97.3%) cases and malignant causes were detected in 6 (2.7%) cases of total 223 cases. The average age of the patients that were diagnosed with malignant disease was 13.3 ± 3.3 years (range 8.7-17 years) and the mean lymphadenomegaly diameter was 3.1 ± 1 cm. The average age of the cases diagnosed with benign disease was 6.6 ± 4.2 years and the mean lymphadenomegaly diameter was 1.6 ± 0.9 cm. The median follow-up for 208 of 223 evaluable patients was 2 months (range, 1 to 12 months) in patients with a benign clinical picture and no patient had a malignant tumor. conclusion: Primary diagnostic evaluation is based mainly on clinical and physical examinations in children with lymph node enlargement

Keywords: Child, Lymph nodes, Neoplasms

References

  1. Ferrer R. Lymphadenopathy: Differential diagnosis and evaluation. Am Fam Physician 1998;58:1313-20.
  2. Oguz A, Karadeniz C, Temel EA, Citak EC, Okur FV. Evaluation of peripheral lymphadenopathy in children. Pediatr Hematol Oncol 2006;23:549-61.
  3. Kelly CS, Kelly RE Jr. Lymphadenopathy in children. Pediatr Clin North Am 1998;45:875-88.
  4. Knight PJ, Mulne AF, Vassy LE. When is lymph node biopsy indicated in children with enlarged peripheral nodes? Pediatrics 1982;69:391-6.
  5. Öksüz RYÇ, Dağdemir A, Acar S, Elli M, Öksüz M. Çocukluk çağı periferik lenfadenomegalili olguların retrospektif değerlendirilmesi. OMÜ Tıp Dergisi 2008;25:94–101.
  6. Citak EC, Koku N, Demirci M, Tanyeri B, Deniz H: A retrospective chart review of evaluation of the cervical lymphadenopathies in children. Auris Nasus Larynx 2011;38:618–21.
  7. Leung AK, Robson WL. Childhood cervical lymphadenopathy. J Pediatr Health Care 2004;18:3-7.
  8. Dulin MF, Kennard TP, Leach L, Williams R. Management of cervical lymphadenitis in children. Am Fam Physician 2008;78:1097-8.
  9. Genç DB. Approach to childhood lymphadenopathy. Journal of Pediatric Research 2014;1:6-12.
  10. Bazemore AW, Smucker DR. Lymphadenopathy and malignancy. Am Fam Physician 2002;66:2103-11.
  11. Reiter A, Ferrando AA. Lympadenopathy. In: Orkin SH, Fisher DE, Look AT, Lux SE, Gingsburg D, Nathan DG (eds). Oncology of Infancy and Childhood. 1st ed. Philadelphia: Saunders Elsevier, 2009:485-8.
  12. Çalkavur Ş, Yalaz M, Kütükçüler N, Özkınay F, Kansoy S, Kültürsay N. Omenn sendromlu bir olgu. Türkiye Çocuk Hast Derg 2013;1: 40-3.
  13. Barton LL. Childhood cervical adenitis. Am Fam Physician 1984; 29:163–6.
  14. Adesuwa Olu-Eddo N, Egbagbe EE. Peripheral lymphadenopathy in Nigerian children. Niger J Clin Pract 2006;9:134-8.
  15. Hafez NH, Tahoun NS. Reliability of fine needle aspiration cytology (FNAC) as a diagnostic tool in cases of cervical lymphadenopathy. J Egypt Natl Canc Inst 2011;23:105-14.
  16. Agrawal H, Gonsai RN, Singal S, Goswami HM. Fine needle aspiration (fnac) as a diagnostic tool ın paediatric lymphadenopathy. Int J Cur Res Rev 2014;6:39-43.
  17. Yarış N, Çakır M, Sözen E, Cobanoglu U. Analysis of children with peripheral lymphadenopathy. Clin Pediatr 2006;45:544-9.

How to cite

1.
Ayçiçek A, Erdoğan B. Prospective Evaluation of 223 Children with Lymphadenomegaly. Turk J Pediatr Dis [Internet]. 2015 Aug. 1 [cited 2025 May 24];9(3):161-6. Available from: https://turkjpediatrdis.org/article/view/315